Pricing
  1. US-listed companies
  2. SOLENO THERAPEUTICS INC
  3. Financials
  4. Total non-current liabilities

SOLENO THERAPEUTICS INC (SLNO)

Market cap
$1.9B
P/E ratio
SummaryFinancials
Period EndTotal non-current liabilities (Million USD)YoY (%)
Dec 31, 202467+474.64%
Dec 31, 202312+32.18%
Dec 31, 20229-9.40%
Dec 31, 202110-9.84%
Dec 31, 202011-40.76%
Dec 31, 201918+68.13%
Dec 31, 201811+1.00%
Dec 31, 201711+2446.67%
Dec 31, 20160

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat